Back
Lonza Group Vs. NLS Pharmaceutics Industry Stock Comparison
Buy
65
LZAGF
Lonza Group
Last Price:
586.33
Seasonality Move:
15.09%
Sell
34
NLSP
NLS Pharmaceutics
Last Price:
0.13
Seasonality Move:
-39.64%
Buy
65
Lonza Group (LZAGF)
is a Buy
Is Lonza Group a Buy, Sell or Hold?
- The current Lonza Group [LZAGF] share price is $586.33. The Score for LZAGF is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
- LZAGF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
34
NLS Pharmaceutics (NLSP)
is a Sell
Is NLS Pharmaceutics a Buy, Sell or Hold?
- The current NLS Pharmaceutics [NLSP] share price is $0.14. The Score for NLSP is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- NLSP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LZAGF Stock Price Chart
What is Lonza Group's stock price today?
-
The Lonza Group share price today is $586.33
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LZAGF is experiencing buying pressure, which is a positive indicator for future bullish movement.
NLSP Stock Price Chart
What is NLS Pharmaceutics's stock price today?
-
The NLS Pharmaceutics share price today is $0.14
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NLSP is experiencing buying pressure, which is a positive indicator for future bullish movement.
LZAGF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.09 | Sell |
| Relative Strength Index (14 RSI): | 56.01 | Buy |
| Chaikin Money Flow: | 82 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (554.29 - 597.49) | Buy |
| Bollinger Bands (100): | (434.56 - 575.16) | Buy |
NLSP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 35.13 | Sell |
| Chaikin Money Flow: | 28541 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.13 - 0.15) | Sell |
| Bollinger Bands (100): | (0.2 - 0.5) | Sell |
LZAGF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 560.48 | Buy |
| 20-day SMA: | 569.46 | Buy |
| 50-day SMA: | 561.66 | Buy |
| 200-day SMA: | 487.33 | Buy |
| 8-day EMA: | 564.74 | Buy |
| 20-day EMA: | 566.46 | Buy |
| 50-day EMA: | 553.36 | Buy |
| 200-day EMA: | 515.28 | Buy |
NLSP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.14 | Buy |
| 20-day SMA: | 0.14 | Sell |
| 50-day SMA: | 0.22 | Sell |
| 200-day SMA: | 0.55 | Sell |
| 8-day EMA: | 0.14 | Buy |
| 20-day EMA: | 0.15 | Sell |
| 50-day EMA: | 0.22 | Sell |
| 200-day EMA: | 0.51 | Sell |
Lonza Group Earnings Growth & LZAGF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
NLS Pharmaceutics Earnings Growth & NLSP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Lonza Group Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NLS Pharmaceutics Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||